Cediranib (AZD2171)

• Catalog number
  1613-5
• Price
  Please ask
• Size
  5 mg

• Alternative_name
  AZD2171, Recentin
• Description
  Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.
• CAS Number
  288383-20-0
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₂₅H₂₇FN₄O₃
• Molecular Weight
  450.51
• Cell Permeable
  Yes
• Purity
  ≥98%
• Solubilities
  DMSO (10 mM)
• Handling
  Protect from air and moisture
• Tag Line
  A VEGFR and c-Kit kinase inhibitor
• Storage Condition
  -20°C
• Shipping Condition
  RT
• Shelf Life
  24months
• MDL Number
  MFCD09954115
• PubChem CID
  9933475
• PubChem CID Link
• SMILES
  CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5
• InChi
  InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22 (31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H, 3-5,8-11H2,1-2H3
• InChi Key
  XXJWYDDUDKYVKI-UHFFFAOYSA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  Cediranib   AZD2171  
• Short name
  Cediranib (AZD2171)
• Alternative name
  Cediranib (AZD2171)

Similar products